PG-27

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NamePG-27
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPharmagenesis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmagenesis
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A